A single-center open-label ADME study to characterize pharmacokinetics and disposition of Contezolid in human and activity of metabolites of Contezolid
Latest Information Update: 20 Aug 2021
Price :
$35 *
At a glance
- Drugs Contezolid (Primary)
- Indications Gram-positive infections; Skin and soft tissue infections; Tuberculosis
- Focus Adverse reactions; Pharmacokinetics
- 20 Aug 2021 New trial record
- 16 Aug 2021 Results published in the Antimicrobial Agents and Chemotherapy